Product Images Montelukast Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Montelukast Sodium NDC 68788-9438 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Montelukast Sodium Tablets 10mg - montelukast 10mg 30

Montelukast Sodium Tablets 10mg - montelukast 10mg 30

This is a description of Montelukast Sodium Tablets, a generic version of the drug Singulair used for treating asthma and allergic rhinitis. Each film-coated tablet contains 10.4mg of Montelukast Sodium USP eq. to 10mg. The tablets are produced by Accord Healthcare Inc. and come in a package size where the expiration date and lot number need to be filled in. The label includes a warning that federal law prohibits the transfer of this drug to anyone other than the patient for whom it was prescribed. The remaining text is related to the number of tablets, insurance, and billing information, which are not useful for a generic description of the product.*

image of figure 1 - montelukast fig1

image of figure 1 - montelukast fig1

This text is describing data related to the mean percent change from baseline for a treatment involving Montelukast Sodium Tablets. It includes information on the weeks in treatment and shows a pattern of T values for each week. However, without additional context or further details, the purpose and conclusion of this data cannot be determined.*

image of chemical structure - montelukast str

image of chemical structure - montelukast str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.